Corcept Therapeutics (CORT) Total Liabilities (2010 - 2026)
Corcept Therapeutics (CORT) posted Total Liabilities of $182.9 million for Q2 2026, up 3.41% sequentially from $176.9 million in Q1 2026, and up 10.24% YoY from $165.9 million in Q2 2025.
Corcept Therapeutics (CORT) Total Liabilities (2010 - 2026) Analysis & Trends
Corcept Therapeutics has reported Total Liabilities for 17 years, with the latest figure at $182.9 million in Q2 2026.
- Quarterly Total Liabilities rose 10.24% year-over-year to $182.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $182.9 million (up 10.24% YoY) and the FY2025 annual result came in at $188.8 million, up 17.32% from the prior year.
- Total Liabilities climbed to $182.9 million in Q2 2026 per CORT's latest filing, from $176.9 million in the prior quarter.
- Over five years, Total Liabilities peaked at $191.7 million in Q3 2025 and troughed at $54.0 million in Q2 2022.
- A 5-year average of $127.6 million and a median of $125.3 million in 2023 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2023 and 2026: Total Liabilities surged 120.97% in 2023, then advanced 8.41% in 2026.
- Over 5 years, Total Liabilities stood at $81.6 million in 2022, then surged by 40.72% to $114.8 million in 2023, then surged by 40.2% to $161.0 million in 2024, then increased by 17.32% to $188.8 million in 2025, then dropped by 3.13% to $182.9 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $182.9 million, $176.9 million, and $188.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Corcept Therapeutics | 12.37 Bn | 12.07 Bn | 252.09 Mn | 182.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 182.93 Mn |
| Mar 31, 2026 | 176.89 Mn |
| Dec 31, 2025 | 188.85 Mn |
| Sep 30, 2025 | 191.71 Mn |
| Jun 30, 2025 | 165.93 Mn |
| Mar 31, 2025 | 163.17 Mn |
| Dec 31, 2024 | 160.96 Mn |
| Sep 30, 2024 | 145.42 Mn |
| Jun 30, 2024 | 118.31 Mn |
| Mar 31, 2024 | 108.07 Mn |
| Dec 31, 2023 | 114.81 Mn |
| Sep 30, 2023 | 132.34 Mn |
| Jun 30, 2023 | 103.01 Mn |
| Mar 31, 2023 | 88.26 Mn |
| Dec 31, 2022 | 81.59 Mn |
| Sep 30, 2022 | 59.89 Mn |
| Jun 30, 2022 | 54.04 Mn |
| Mar 31, 2022 | 60.31 Mn |
| Dec 31, 2021 | 47.95 Mn |
| Sep 30, 2021 | 45.17 Mn |